Home › Funds › United Southern Bank - Trust Department › GSK

United Southern Bank - Trust Department position in GSK

GSK PLC · Health Care

United Southern Bank - Trust Department reported holding 42,481 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.48% of its reported portfolio and ranking #13 among its reported holdings. United Southern Bank - Trust Department first reported this position in Q3 2026.

Latest position (Q3 2026)42.48K sh
Reported value held$2.05M
Portfolio Weight1.48%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How United Southern Bank - Trust Department's GSK position evolved

United Southern Bank - Trust Department first disclosed a stake in GSK in Q3 2026 at 42,481 shares (US$2.0M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 42.48K $2.05M New

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.08B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has United Southern Bank - Trust Department held GSK?

United Southern Bank - Trust Department has disclosed GSK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is United Southern Bank - Trust Department's current position in GSK?

As of Q3 2026, United Southern Bank - Trust Department holds 42.48K shares of GSK (GSK PLC), valued at $2.05M, representing 1.48% of its reported portfolio and ranking #13.

Has United Southern Bank - Trust Department been buying or selling GSK?

In the latest 13F filing (Q3 2026), United Southern Bank - Trust Department newly opened its position in GSK.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.